Mark D. Minden
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Oncology 3
- CAR-T cell therapy research 2
-
- Peroxisome Proliferator-Activated Receptors 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Samuel Benchimol (1 shared paper)John Blondal (1 shared paper)H. A. Messner (1 shared paper)Hong Chang (1 shared paper)Monzr M. Al Malki (1 shared paper)Martin Jädersten (1 shared paper)Stanley C. Gill (2 shared papers)Housheng Hansen He (1 shared paper)
- Journals
- Leukemia Research (1 paper)Blood (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Cancer (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark D. Minden
5 papers receiving 41 citations
Peers
Comparison fields: 5 of 16
- Pathology and Forensic Medicine 15
- Genetics 9
- Oncology 15
- Cancer Research 7
- Hematology 4
Countries citing papers authored by Mark D. Minden
This map shows the geographic impact of Mark D. Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Minden more than expected).
Fields of papers citing papers by Mark D. Minden
This network shows the impact of papers produced by Mark D. Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Minden. The network helps show where Mark D. Minden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 33 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 2 | |
| 6 | 2024 | 0 |
About Mark D. Minden
Mark D. Minden is a scholar working on Oncology, Molecular Biology, Hematology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 41 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), CAR-T cell therapy research (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Lung Cancer Treatments and Mutations (1 paper), Immunotherapy and Immune Responses (1 paper), Protein Degradation and Inhibitors (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (15 citations), Genetics (9 citations), Oncology (15 citations), Cancer Research (7 citations) and Hematology (4 citations). Mark D. Minden has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Samuel Benchimol, John Blondal, H. A. Messner, Hong Chang, Monzr M. Al Malki, Martin Jädersten, Stanley C. Gill, Housheng Hansen He, Yingying Yang and Paul A. Spagnuolo. Their work appears in journals such as Leukemia Research, Blood, Journal for ImmunoTherapy of Cancer, Cancer and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.